J2 Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $413K | Buy |
928
+250
| +37% | +$111K | 0.33% | 80 |
|
|
2025
Q1 | $329K | Buy |
678
+7
| +1% | +$3.39K | 0.3% | 74 |
|
|
2024
Q4 | $270K | Buy |
+671
| New | +$270K | 0.25% | 96 |
|
|
2023
Q3 | $422K | Buy |
1,213
+3
| +0.2% | +$1.04K | 0.53% | 49 |
|
|
2023
Q2 | $426K | Buy |
1,210
+34
| +3% | +$12K | 0.51% | 51 |
|
|
2023
Q1 | $371K | Buy |
+1,176
| New | +$371K | 0.57% | 46 |
|
|
2022
Q3 | – | Sell |
-903
| Closed | -$254K | – | 103 |
|
|
2022
Q2 | $254K | Sell |
903
-1,012
| -53% | -$285K | 0.39% | 64 |
|
|
2022
Q1 | $500K | Buy |
1,915
+41
| +2% | +$10.7K | 0.55% | 31 |
|
|
2021
Q4 | $412K | Buy |
+1,874
| New | +$412K | 0.39% | 43 |
|